<DOC>
	<DOCNO>NCT01341756</DOCNO>
	<brief_summary>The hypothesis study radiotherapy dose 36Gy 12 fraction , equate BED 48.6Gy , increase response rate symptom relief compare historical control .</brief_summary>
	<brief_title>Palliative Radiotherapy Symptomatic Locally Advanced Gastric Cancer : A Phase II Trial</brief_title>
	<detailed_description>The hypothesis study radiotherapy dose 36Gy 12 fraction , equate BED 48.6Gy , increase response rate symptom relief compare historical control . ( Tey et al . ) With dose fractionation use bleeding , increase response rate 55 % ( historical ) 75 % pain , increase response rate 25 % ( historical ) 45 % obstruction , increase response rate 25 % ( historical ) 45 %</detailed_description>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<criteria>Biopsy proven adenocarcinoma stomach Treated palliative intent At least one index symptom bleeding , obstruction pain No prior abdominal radiotherapy Not chemotherapy Patients treat radical intent Previous abdominal radiotherapy Patients chemotherapy</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>Gastric Cancer</keyword>
	<keyword>Radiotherapy</keyword>
	<keyword>palliation</keyword>
	<keyword>bleeding</keyword>
	<keyword>pain</keyword>
	<keyword>obstruction</keyword>
</DOC>